Biomedical and Behavioral Infant Screening
Learn more about healthy baby development and develop new tools for pediatricians so they can better support the unique development of each child.
Learn more about healthy baby development and develop new tools for pediatricians so they can better support the unique development of each child.
Determine how potentially stressful situations, including prematurity, hospitalizations, maternal mental health and rapid repeat births can impact a baby’s development in the first 12 months of their life.
1) To determine if 5 doses of Epo (Erythropoietin) 1000 U/kg (birth weight) intravenous (IV) reduces the rate of death or neurodevelopmental impairment (mild, moderate, or severe) at 24 months of age.
2) To assess safety of Epo.
3) To determine whether Epo decreases the severity of HIE-induced brain injury as evidenced by early MRI and plasma biomarkers of brain injury.
We are interested in observing whether and how infants learn when interacting with a robot during a learning assessment contingency paradigm.
The effect of flu immunization on the level of immunity against the flu in breastmilk, and how this may help protect a breastfeeding infant.
Our goal is early identification of deviation from healthy brain development to allow targeted early intervention and improve developmental outcomes.
To better understand the effects of breastfeeding on infant growth and development.
The collection of the research data we hope will help better screening, diagnosing procedures and treatment of brain injury in newborns and identify a connection between MR imaging and neurodevelopmental outcomes.
Develop non-invasive measures to identify abnormal placental function in babies with and without congenital anomalies.
To explore the safety and treatment effect of intravenous (IV) Remodulin as add on therapy in neonates with PPHN compared to placebo.